These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6308461)

  • 1. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis.
    Oostra BA; Harvey R; Ely BK; Markham AF; Smith AE
    Nature; 1983 Aug 4-10; 304(5925):456-9. PubMed ID: 6308461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.
    Mes-Masson AM; Schaffhausen B; Hassell JA
    J Virol; 1984 Nov; 52(2):457-64. PubMed ID: 6092671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of the polyoma virus middle T gene as the oncogene of a murine retrovirus.
    Donoghue DJ; Anderson C; Hunter T; Kaplan PL
    Nature; 1984 Apr 19-25; 308(5961):748-50. PubMed ID: 6325917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
    Carmichael G; Schaffhausen BS; Mandel G; Liang TJ; Benjamin TL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):679-83. PubMed ID: 6322163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual transforming activity of PY1178T, a mutant lacking the principal in vitro tyrosine phosphorylation site, is not affected by removal of the secondary tyrosine phosphorylation site at residue 322.
    Schaffhausen BS; Liang TJ; Carmichael GG; Benjamin TL
    Virology; 1985 Jun; 143(2):671-5. PubMed ID: 2998034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).
    Smart JE; Oppermann H; Czernilofsky AP; Purchio AF; Erikson RL; Bishop JM
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6013-7. PubMed ID: 6273838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyoma virus transforming protein associates with the product of the c-src cellular gene.
    Courtneidge SA; Smith AE
    Nature; 1983 Jun 2-8; 303(5916):435-9. PubMed ID: 6304524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal amino acid sequences of the polyoma middle-size T antigen are important for protein kinase activity and cell transformation.
    Templeton D; Eckhart W
    Mol Cell Biol; 1984 May; 4(5):817-21. PubMed ID: 6328268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino terminus of polyomavirus middle T antigen is required for transformation.
    Cook DN; Hassell JA
    J Virol; 1990 May; 64(5):1879-87. PubMed ID: 2157858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
    Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
    J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.
    Cheng SH; Espino PC; Marshall J; Harvey R; Merrill J; Smith AE
    J Virol; 1991 Jan; 65(1):170-9. PubMed ID: 1985196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of polyomavirus large-T-antigen proteins expressed by mutant genes.
    Nilsson SV; Magnusson G
    J Virol; 1984 Sep; 51(3):768-75. PubMed ID: 6088799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.
    Clark KL; Folk WR
    J Virol; 1986 Jan; 57(1):237-45. PubMed ID: 3001348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.
    Whitman M; Kaplan DR; Schaffhausen B; Cantley L; Roberts TM
    Nature; 1985 May 16-22; 315(6016):239-42. PubMed ID: 2987699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?
    Dalianis T; Ramqvist T; Klein G
    Int J Cancer; 1984 Sep; 34(3):403-6. PubMed ID: 6090322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.
    Markland W; Cheng SH; Oostra BA; Smith AE
    J Virol; 1986 Jul; 59(1):82-9. PubMed ID: 2423706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.